{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T18:56:30Z","timestamp":1785869790668,"version":"3.56.0"},"reference-count":122,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:p>Compared with cancers of other organs, precursor lesions of renal cell neoplasms are rarely discussed. However, there are specific scenarios where cysts or microscopic solid lesions are thought to precede tumor formation. In 2024, the International Society of Urological Pathology (ISUP) held a consensus meeting on precursor lesions of urologic neoplasms in Florence, Italy. This report details the findings of Working Group 3\u2014Precursor Lesions of the Kidney. Papillary adenoma is likely the best-established precursor lesion in the kidney, thought to be an incipient form of papillary renal cell carcinoma (RCC) with shared morphology, immunohistochemistry, and genetics. Likewise, in patients with VHL disease, the kidney often contains multiple small nodules of clear cells and\/or cysts lined by one or more layers of clear cells, likely representing early tumor or precursor lesions. Interestingly, a precursor counterpart for clear cell RCC in the sporadic setting is not well established. In other scenarios, cysts are considered potential precursors of neoplasia, such as those in acquired cystic kidney disease (ACKD) and possibly in some hereditary renal tumor syndromes. The consensus panel proposes the following terms \u201ccyst with epithelial proliferation\u201d for tufted\/hyperplastic\/cribriform cyst lining in ACKD without solid tumor, and \u201cpapillary hyperplasia\u201d for tufting of cyst lining in autosomal dominant polycystic kidney. Terms such as \u201ctumorlet,\u201d \u201cmicrotumor,\u201d or \u201cincipient tumor\u201d are acceptable for incidental unencapsulated microscopic lesions in hereditary syndrome patients. There is insufficient evidence for the diagnosis of \u201ctubular dysplasia\u201d as a precursor to RCC at the present time.<\/jats:p>","DOI":"10.1097\/pas.0000000000002550","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T19:01:21Z","timestamp":1777489281000},"page":"e32-e47","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["International Society of Urological Pathology Consensus on Cancer Precursor Lesions"],"prefix":"10.1097","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3898-1460","authenticated-orcid":false,"given":"Sean R.","family":"Williamson","sequence":"first","affiliation":[{"name":"Department of Pathology, Diagnostics Institute, Cleveland Clinic, Cleveland, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara E.","family":"Wobker","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of North Carolina (UNC) School of Medicine, Chapel Hill, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit","family":"Mehra","sequence":"additional","affiliation":[{"name":"Department of Pathology and Michigan Center for Translational Pathology, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaleel I.","family":"Al-Obaidy","sequence":"additional","affiliation":[{"name":"McLaren Pathology Group, McLaren Health Care, Flint, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Martignoni","sequence":"additional","affiliation":[{"name":"Department of Diagnostics and Public Health, Section of Pathology, University of Verona, Verona"},{"name":"Department of Pathology, Pederzoli Hospital, Peschiera del Garda, Veneto, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sambit","family":"Mohanty","sequence":"additional","affiliation":[{"name":"Department of Pathology, Core Diagnostics, Gurgaon, Haryana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven C.","family":"Smith","sequence":"additional","affiliation":[{"name":"Department of Pathology, VCU Health, Virginia Commonwealth University, Richmond, VA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puay Hoon","family":"Tan","sequence":"additional","affiliation":[{"name":"Luma Medical Centre, Singapore, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Tretiakova","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, University of Washington Medical Center, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Payal","family":"Kapur","sequence":"additional","affiliation":[{"name":"Department of Pathology and Department of Urology, UT Southwestern Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chin Lee","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Pathology, Massachusetts General Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmut","family":"Akgul","sequence":"additional","affiliation":[{"name":"Department of Pathology, Brigham and Women\u2019s Hospital, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankur R.","family":"Sangoi","sequence":"additional","affiliation":[{"name":"Department of Pathology, Stanford University, Palo Alto"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Ari","family":"Hakimi","sequence":"additional","affiliation":[{"name":"Urology Service and Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Shuch","sequence":"additional","affiliation":[{"name":"Department of Urology, University of California, Los Angeles (UCLA), Los Angeles, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Brugarolas","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Hematology\/Oncology, UT Southwestern Medical Center, Dallas, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glen","family":"Kristiansen","sequence":"additional","affiliation":[{"name":"Institute of Pathology, University Hospital Bonn, Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Department of Surgery (Urology), Brown University Warren Alpert Medical School, the Legorreta Cancer Center at Brown University, and Brown University Health, Providence, RI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Moch","sequence":"additional","affiliation":[{"name":"Department of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"And the Members of the ISUP GU Cancer Precursor Consensus Panel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,4,29]]},"reference":[{"key":"R1-20260513","first-page":"125","article-title":"Histopathology and classification of renal cell tumors (adenomas, oncocytomas and carcinomas)","volume":"181","author":"Thoenes","year":"1986","journal-title":"The basic cytological and histopathological elements and their use for diagnostics Pathol Res Pract"},{"key":"R2-20260513","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1158\/2159-8290.CD-17-0292","article-title":"Modeling renal cell carcinoma in mice: Bap1 and Pbrm1 inactivation drive tumor grade","volume":"7","author":"Gu","year":"2017","journal-title":"Cancer Discov"},{"key":"R3-20260513","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1126\/science.aat1699","article-title":"Single-cell transcriptomes from human kidneys reveal the cellular identity of renal tumors","volume":"361","author":"Young","year":"2018","journal-title":"Science"},{"key":"R4-20260513","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/s41597-023-02209-9","article-title":"Meta-analysis of single-cell and single-nucleus transcriptomics reveals kidney cell type consensus signatures","volume":"10","author":"Quatredeniers","year":"2023","journal-title":"Sci Data"},{"key":"R5-20260513","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41467-021-27660-3","article-title":"Single-cell chromatin accessibility landscape in kidney identifies additional cell-of- origin in heterogenous papillary renal cell carcinoma","volume":"13","author":"Wang","year":"2022","journal-title":"Nat Commun"},{"key":"R6-20260513","doi-asserted-by":"crossref","first-page":"8383","DOI":"10.1038\/s41467-023-44159-1","article-title":"Genomic and epigenomic integrative subtypes of renal cell carcinoma in a Japanese cohort","volume":"14","author":"Fukagawa","year":"2023","journal-title":"Nat Commun"},{"key":"R7-20260513","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1097\/PAS.0000000000001150","article-title":"VSTM2A overexpression is a sensitive and specific biomarker for mucinous tubular and spindle cell carcinoma (MTSCC) of the kidney","volume":"42","author":"Wang","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"R8-20260513","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1177\/10668969221125793","article-title":"Characterization of intercalated cell markers KIT and LINC01187 in chromophobe renal cell carcinoma and other renal neoplasms","volume":"31","author":"Mannan","year":"2023","journal-title":"Int J Surg Pathol"},{"key":"R9-20260513","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1038\/s41379-021-00803-z","article-title":"TRIM63 is a sensitive and specific biomarker for MiT family aberration-associated renal cell carcinoma","volume":"34","author":"Wang","year":"2021","journal-title":"Mod Pathol"},{"key":"R10-20260513","doi-asserted-by":"crossref","first-page":"e170559","DOI":"10.1172\/JCI170559","article-title":"Comparative genomics incorporating translocation renal cell carcinoma mouse model reveals molecular mechanisms of tumorigenesis","volume":"134","author":"Prakasam","year":"2024","journal-title":"J Clin Investig"},{"key":"R11-20260513","doi-asserted-by":"crossref","first-page":"16538","DOI":"10.1073\/pnas.1414789111","article-title":"Bap1 is essential for kidney function and cooperates with Vhl in renal tumorigenesis","volume":"111","author":"Wang","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"R12-20260513","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/nrurol.2017.112","article-title":"consortium TRR. TRACERx Renal: tracking renal cancer evolution through therapy","volume":"14","year":"2017","journal-title":"Nat Rev Urol"},{"key":"R13-20260513","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.cell.2018.02.020","article-title":"Timing the landmark events in the evolution of clear cell renal cell cancer: TRACERx renal","volume":"173","author":"Mitchell","year":"2018","journal-title":"Cell"},{"key":"R14-20260513","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1097\/PAS.0000000000001476","article-title":"Report From the International Society of Urological Pathology (ISUP) Consultation conference on molecular pathology of urogenital cancers: III: molecular pathology of kidney cancer","volume":"44","author":"Williamson","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"R15-20260513","first-page":"e170559","article-title":"Single-cell analyses of renal cell cancers reveal insights into tumor microenvironment, cell of origin, and therapy response","volume":"118","author":"Zhang","year":"2021","journal-title":"Proc Natl Acad Sci USA"},{"key":"R16-20260513","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1158\/0008-5472.CAN-22-2224","article-title":"Integrative single-cell analysis reveals transcriptional and epigenetic regulatory features of clear cell renal cell carcinoma","volume":"83","author":"Yu","year":"2023","journal-title":"Cancer Res"},{"key":"R17-20260513","doi-asserted-by":"crossref","first-page":"101547","DOI":"10.1016\/j.xcrm.2024.101547","article-title":"Comprehensive proteogenomic characterization of rare kidney tumors","volume":"5","author":"Li","year":"2024","journal-title":"Cell Rep Med"},{"key":"R18-20260513","doi-asserted-by":"crossref","first-page":"100540","DOI":"10.1016\/j.modpat.2024.100540","article-title":"Expression of L1 cell adhesion molecule, a nephronal principal cell marker, in nephrogenic adenoma","volume":"37","author":"Mannan","year":"2024","journal-title":"Mod Pathol"},{"key":"R19-20260513","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.eururo.2020.03.003","article-title":"Next-generation RNA sequencing-based biomarker characterization of chromophobe renal cell carcinoma and related oncocytic neoplasms","volume":"78","author":"Skala","year":"2020","journal-title":"Eur Urol"},{"key":"R20-20260513","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/PAS.0000000000002152","article-title":"Hybrid oncocytic tumors (HOTs) in Birt-Hogg-Dube syndrome patients-a tale of two cities: sequencing analysis reveals dual lineage markers capturing the 2 cellular populations of HOT","volume":"48","author":"Wang","year":"2024","journal-title":"Am J Surg Pathol"},{"key":"R21-20260513","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.eururo.2025.03.012","article-title":"Renal neoplasia in Birt- Hogg-Dube syndrome: integrated histopathologic, bulk, and single-cell transcriptomic analysis","volume":"88","author":"Gupta","year":"2025","journal-title":"European urology"},{"key":"R22-20260513","doi-asserted-by":"crossref","first-page":"100467","DOI":"10.1016\/j.modpat.2024.100467","article-title":"L1 cell adhesion molecule (L1CAM) expression and molecular alterations distinguish low-grade oncocytic tumor from eosinophilic chromophobe renal cell carcinoma","volume":"37","author":"Alghamdi","year":"2024","journal-title":"Mod Pathol"},{"key":"R23-20260513","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1097\/00000478-199411000-00005","article-title":"Dysplastic tubular epithelium in \u201cnormal\u201d kidney associated with renal cell carcinoma","volume":"18","author":"Mourad","year":"1994","journal-title":"Am J Surg Pathol"},{"key":"R24-20260513","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/S0090-4295(98)00580-9","article-title":"Tubular dysplasia and carcinoma in situ: precursors of renal cell carcinoma","volume":"53","author":"Yorukoglu","year":"1999","journal-title":"Urology"},{"key":"R25-20260513","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1080\/00313020126311","article-title":"Test and teach. Is it cancer? Renal tubular epithelial dysplasia","volume":"33","author":"Dahlstrom","year":"2001","journal-title":"Pathology"},{"key":"R26-20260513","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/PAS.0000000000001680","article-title":"Distal tubular hyperplasia: a proposal for a unique form of renal tubular proliferation distinct from papillary adenoma","volume":"45","author":"Williamson","year":"2021","journal-title":"Am J Surg Pathol"},{"key":"R27-20260513","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1126\/science.8493574","article-title":"Identification of the von Hippel- Lindau disease tumor suppressor gene","volume":"260","author":"Latif","year":"1993","journal-title":"Science"},{"key":"R28-20260513","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/S0022-5347(01)62509-6","article-title":"Prevalence, morphology and biology of renal cell carcinoma in von Hippel- Lindau disease compared to sporadic renal cell carcinoma","volume":"160","author":"Neumann","year":"1998","journal-title":"J Urol"},{"key":"R29-20260513","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1535-6108(02)00071-5","article-title":"HIF activation identifies early lesions in VHL kidneys: evidence for site-specific tumor suppressor function in the nephron","volume":"1","author":"Mandriota","year":"2002","journal-title":"Cancer Cell"},{"key":"R30-20260513","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.humpath.2014.02.014","article-title":"Pathologic spectrum of cysts in end-stage kidneys: possible precursors to renal neoplasia","volume":"45","author":"Hosseini","year":"2014","journal-title":"Hum Pathol"},{"key":"R31-20260513","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1146\/annurev-pathol-012414-040306","article-title":"A clearer view of the molecular complexity of clear cell renal cell carcinoma","volume":"10","author":"Frew","year":"2015","journal-title":"Annu Rev Pathol Mech Dis"},{"key":"R32-20260513","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/emmm.201202231","article-title":"Combined mutation of Vhl and Trp53 causes renal cysts and tumours in mice","volume":"5","author":"Albers","year":"2013","journal-title":"EMBO Mol Med"},{"key":"R33-20260513","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1038\/emboj.2008.96","article-title":"pVHL and PTEN tumour suppressor proteins cooperatively suppress kidney cyst formation","volume":"27","author":"Frew","year":"2008","journal-title":"Embo J"},{"key":"R34-20260513","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/modpathol.2010.222","article-title":"VHL mutations and dysregulation of pVHL- and PTEN-controlled pathways in multilocular cystic renal cell carcinoma","volume":"24","author":"von Teichman","year":"2011","journal-title":"Mod Pathol"},{"key":"R35-20260513","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/ng0594-85","article-title":"Mutations of the VHL tumour suppressor gene in renal carcinoma","volume":"7","author":"Gnarra","year":"1994","journal-title":"Nat Genet"},{"key":"R36-20260513","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1113205","article-title":"Intratumor heterogeneity and branched evolution revealed by multiregion sequencing","volume":"366","author":"Gerlinger","year":"2012","journal-title":"New Engl J Med"},{"key":"R37-20260513","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.cell.2018.03.057","article-title":"Tracking cancer evolution reveals constrained routes to metastases: TRACERx renal","volume":"173","author":"Turajlic","year":"2018","journal-title":"Cell"},{"key":"R38-20260513","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/ng.2891","article-title":"Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing","volume":"46","author":"Gerlinger","year":"2014","journal-title":"Nat Genet"},{"key":"R39-20260513","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/ncomms1814","article-title":"Reliable detection of subclonal single-nucleotide variants in tumour cell populations","volume":"3","author":"Gerstung","year":"2012","journal-title":"Nat Commun"},{"key":"R40-20260513","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/PCR.0000000000000023","article-title":"The pathology of von Hippel-Lindau disease","volume":"19","author":"Guo","year":"2014","journal-title":"Pathol Case Rev"},{"key":"R42-20260513","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/PAP.0b013e3181d98c9d","article-title":"Cystic renal tumors: new entities and novel concepts","volume":"17","author":"Moch","year":"2010","journal-title":"Adv Anat Pathol"},{"key":"R43-20260513","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.cll.2005.01.007","article-title":"History of the development of the classification of renal cell neoplasia","volume":"25","author":"Delahunt","year":"2005","journal-title":"Clin Lab Med"},{"key":"R45-20260513","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/modpathol.2010.78","article-title":"Multilocular cystic renal cell carcinoma is a subtype of clear cell renal cell carcinoma","volume":"23","author":"Halat","year":"2010","journal-title":"Mod Pathol"},{"key":"R46-20260513","doi-asserted-by":"crossref","first-page":"831","DOI":"10.3390\/cancers14030831","article-title":"A comprehensive commentary on the multilocular cystic renal neoplasm of low malignant potential: a urologist\u2019s perspective","volume":"14","author":"Pitra","year":"2022","journal-title":"Cancers (Basel)"},{"key":"R47-20260513","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1309\/AH6FC77PYR2V6YAY","article-title":"Multilocular cystic renal cell carcinoma : a report of 45 cases of a kidney tumor of low malignant potential","volume":"125","author":"Suzigan","year":"2006","journal-title":"Am J Clin Pathol"},{"key":"R48-20260513","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.humpath.2006.07.016","article-title":"Renal papillary adenoma\u2013a putative precursor of papillary renal cell carcinoma","volume":"38","author":"Wang","year":"2007","journal-title":"Hum Pathol"},{"key":"R49-20260513","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1016\/j.ajpath.2019.07.002","article-title":"Integrated molecular analysis of papillary renal cell carcinoma and precursor lesions unfolds evolutionary process from kidney progenitor-like cells","volume":"189","author":"Saleeb","year":"2019","journal-title":"Am J Pathol"},{"key":"R50-20260513","first-page":"301","article-title":"Parenchymal abnormalities associated with papillary renal cell tumors","volume":"1","author":"Kovacs","year":"1993","journal-title":"J Urol Pathol"},{"key":"R51-20260513","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/PAS.0000000000001189","article-title":"Papillary adenomas and other small epithelial tumors in the kidney: an autopsy study","volume":"43","author":"Calio","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"R52-20260513","article-title":"Recurrent kras mutation is an early event in the development of papillary renal neoplasm with reverse polarity","author":"Al-Obaidy","year":"2020"},{"key":"R53-20260513","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1097\/PAS.0000000000001288","article-title":"Papillary renal neoplasm with reverse polarity: a morphologic, immunohistochemical, and molecular study","volume":"43","author":"Al-Obaidy","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"R54-20260513","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/s41379-019-0362-1","article-title":"Recurrent KRAS mutations in papillary renal neoplasm with reverse polarity","volume":"33","author":"Al-Obaidy","year":"2020","journal-title":"Mod Pathol"},{"key":"R56-20260513","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.pathol.2020.09.015","article-title":"Chromophobe renal cell carcinoma: current and controversial issues","volume":"53","author":"Moch","year":"2021","journal-title":"Pathology"},{"key":"R57-20260513","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/ng.3146","article-title":"Spectrum of diverse genomic alterations define non-clear cell renal carcinoma subtypes","volume":"47","author":"Durinck","year":"2015","journal-title":"Nat Genet"},{"key":"R58-20260513","doi-asserted-by":"crossref","first-page":"e170559","DOI":"10.1172\/jci.insight.176743","article-title":"Molecular underpinnings of dedifferentiation and aggressiveness in chromophobe renal cell carcinoma","volume":"9","author":"Kapur","year":"2024","journal-title":"JCI Insight"},{"key":"R59-20260513","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1038\/s41379-019-0304-y","article-title":"Hybrid oncocytic\/ chromophobe renal tumors are molecularly distinct from oncocytoma and chromophobe renal cell carcinoma","volume":"32","author":"Ruiz-Cordero","year":"2019","journal-title":"Mod Pathol"},{"key":"R60-20260513","first-page":"949","article-title":"Low-grade oncocytic tumour expands the spectrum of renal oncocytic tumours and deserves separate classification: a review of 23 cases from a single tertiary institute","volume":"5","author":"Akgul","year":"2021","journal-title":"J Clin Pathol"},{"key":"R61-20260513","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/s41379-021-00896-6","article-title":"Germline and sporadic mTOR pathway mutations in low-grade oncocytic tumor of the kidney","volume":"35","author":"Kapur","year":"2022","journal-title":"Mod Pathol"},{"key":"R62-20260513","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.humpath.2021.04.013","article-title":"Low-grade oncocytic tumor of kidney (CK7-Positive, CD117-Negative): incidence in a single institutional experience with clinicopathological and molecular characteristics","volume":"114","author":"Kravtsov","year":"2021","journal-title":"Hum Pathol"},{"key":"R63-20260513","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/s41379-021-00906-7","article-title":"Low-grade oncocytic renal tumor (LOT): mutations in mTOR pathway genes and low expression of FOXI1","volume":"35","author":"Morini","year":"2022","journal-title":"Mod Pathol"},{"key":"R64-20260513","doi-asserted-by":"crossref","first-page":"e170559","DOI":"10.3390\/cancers12010168","article-title":"ESC, ALK, HOT and LOT: three letter acronyms of emerging renal entities knocking on the door of the WHO classification","volume":"12","author":"Siadat","year":"2020","journal-title":"Cancers (Basel)"},{"key":"R65-20260513","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/his.13865","article-title":"Low-grade oncocytic tumour of kidney (CD117-negative, cytokeratin 7-positive): a distinct entity?","volume":"75","author":"Trpkov","year":"2019","journal-title":"Histopathology"},{"key":"R66-20260513","doi-asserted-by":"crossref","first-page":"1610852","DOI":"10.3389\/pore.2023.1610852","article-title":"Low-grade oncocytic tumour (LOT) of the kidney is characterised by GATA3 positivity, FOXI1 negativity and mTOR pathway mutations","volume":"29","author":"Chen","year":"2023","journal-title":"Pathol Oncol Res"},{"key":"R67-20260513","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/his.14816","article-title":"Low-grade oncocytic tumour of the kidney is characterised by genetic alterations of TSC1, TSC2, MTOR or PIK3CA and consistent GATA3 positivity","volume":"82","author":"Williamson","year":"2023","journal-title":"Histopathology"},{"key":"R68-20260513","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1177\/10668969231178032","article-title":"Concordance of MTOR pathway mutations and the diagnosis of renal low-grade oncocytic tumor (LOT)","volume":"32","author":"Siegmund","year":"2024","journal-title":"Int J Surg Pathol"},{"key":"R69-20260513","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/his.70037","article-title":"Eosinophilic vacuolated tumour has metastatic potential","volume":"88","author":"Coiner","year":"2026","journal-title":"Histopathology"},{"key":"R70-20260513","doi-asserted-by":"crossref","first-page":"162","DOI":"10.32074\/1591-951X-1122","article-title":"Eosinophilic vacuolated tumor of the kidney can have distant metastasis: a histo-molecular case study","volume":"117","author":"Liu","year":"2025","journal-title":"Pathologica"},{"key":"R71-20260513","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.pathol.2020.10.002","article-title":"Clear cell papillary renal cell carcinoma: an update after 15 years","volume":"53","author":"Williamson","year":"2021","journal-title":"Pathology"},{"key":"R73-20260513","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1097\/PAS.0000000000000514","article-title":"Clear cell renal cell carcinoma with borderline features of clear cell papillary renal cell carcinoma: combined morphologic, immunohistochemical, and cytogenetic analysis","volume":"39","author":"Williamson","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"R74-20260513","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/PAS.0000000000000583","article-title":"Renal neoplasms with overlapping features of clear cell renal cell carcinoma and clear cell papillary renal cell carcinoma: a clinicopathologic study of 37 cases from a single institution","volume":"40","author":"Dhakal","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R75-20260513","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1177\/10668969221145011","article-title":"A Sarcomatoid renal cell carcinoma with clear cell papillary-like primary tumor and lymph node metastasis: a diagnostic conundrum","volume":"31","author":"Demko","year":"2023","journal-title":"Int J Surg Pathol"},{"key":"R76-20260513","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1097\/PAS.0000000000000513","article-title":"Do clear cell papillary renal cell carcinomas have malignant potential?","volume":"39","author":"Diolombi","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"R77-20260513","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1097\/PAS.0b013e318282dab8","article-title":"Clear cell papillary renal cell carcinoma-like tumors in patients with von Hippel-Lindau disease are unrelated to sproadic clear cell papillary renal cell carcinoma","volume":"37","author":"Williamson","year":"2013","journal-title":"Am J Surg Path"},{"key":"R78-20260513","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1111\/his.15166","article-title":"Vascular, adipose tissue, and\/or calyceal invasion in clear cell tubulopapillary renal cell tumour: potentially problematic diagnostic scenarios","volume":"84","author":"Sangoi","year":"2024","journal-title":"Histopathology"},{"key":"R79-20260513","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.humpath.2016.07.020","article-title":"Renal oncocytoma with vascular invasion: a series of 22 cases","volume":"58","author":"Wobker","year":"2016","journal-title":"Hum Pathol"},{"key":"R80-20260513","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1111\/his.14071","article-title":"Defining clear cell papillary renal cell carcinoma in routine clinical practice","volume":"76","author":"Gupta","year":"2020","journal-title":"Histopathology"},{"key":"R81-20260513","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1111\/his.15123","article-title":"Metastatic clear cell papillary renal cell \u2018tumour","volume":"84","author":"Gupta","year":"2024","journal-title":"Histopathology"},{"key":"R82-20260513","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/s41379-019-0420-8","article-title":"Recurrent KRAS mutations identified in papillary renal neoplasm with reverse polarity-a comparative study with papillary renal cell carcinoma","volume":"33","author":"Kim","year":"2020","journal-title":"Mod Pathol"},{"key":"R83-20260513","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1177\/1066896920918289","article-title":"Papillary renal neoplasm with reverse polarity: a clinicopathologic study of 7 cases","volume":"28","author":"Zhou","year":"2020","journal-title":"Int J Surg Pathol"},{"key":"R84-20260513","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/s41379-019-0362-1","article-title":"Recurrent KRAS mutations in papillary renal neoplasm with reverse polarity","volume":"33","author":"Al-Obaidy","year":"2020","journal-title":"Mod Pathol"},{"key":"R85-20260513","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/his.14320","article-title":"Clinicopathological and molecular characterisation of papillary renal neoplasm with reverse polarity and its renal papillary adenoma analogue","volume":"78","author":"Chang","year":"2021","journal-title":"Histopathology"},{"key":"R86-20260513","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/PAS.0000000000001773","article-title":"Papillary renal neoplasm with reverse polarity is often cystic: report of 7 cases and review of 93 cases in the literature","volume":"46","author":"Wei","year":"2022","journal-title":"Am J Surg Pathol"},{"key":"R87-20260513","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.humpath.2023.09.011","article-title":"Papillary renal neoplasm with reverse polarity: a clinicopathologic study of 43 cases with a focus on the expression of KRAS signaling pathway downstream effectors","volume":"142","author":"Kim","year":"2023","journal-title":"Hum Pathol"},{"key":"R88-20260513","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/pin.13417","article-title":"Papillary renal neoplasm with reverse polarity is biologically and clinically distinct from eosinophilic papillary renal cell carcinoma","volume":"74","author":"Castillo","year":"2024","journal-title":"Pathol Int"},{"key":"R89-20260513","doi-asserted-by":"crossref","first-page":"152498","DOI":"10.1016\/j.anndiagpath.2025.152498","article-title":"Papillary renal neoplasm with reverse polarity shows benign behavior: Results from a 77-case clinicopathological and molecular study","volume":"80","author":"Lee","year":"2025","journal-title":"Ann Diagn Pathol"},{"key":"R90-20260513","doi-asserted-by":"crossref","first-page":"152530","DOI":"10.1016\/j.anndiagpath.2025.152530","article-title":"Papillary renal neoplasm with reverse polarity: A distinct entity ready for the World Health Organization classification","volume":"80","author":"Williamson","year":"2025","journal-title":"Ann Diagn Pathol"},{"key":"R91-20260513","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1038\/s41379-022-01018-6","article-title":"Recurrent KRAS mutations are early events in the development of papillary renal neoplasm with reverse polarity","volume":"35","author":"Al-Obaidy","year":"2022","journal-title":"Mod Pathol"},{"key":"R92-20260513","doi-asserted-by":"crossref","first-page":"657","DOI":"10.3390\/biomedicines10030657","article-title":"Renal cell carcinoma in end-stage renal disease: a review and update","volume":"10","author":"El-Zaatari","year":"2022","journal-title":"Biomedicines"},{"key":"R93-20260513","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3389\/fonc.2012.00028","article-title":"End stage and chronic kidney disease: associations with renal cancer","volume":"2","author":"Russo","year":"2012","journal-title":"Front Oncol"},{"key":"R94-20260513","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/path.2176","article-title":"Oxidative stress and DNA hypermethylation status in renal cell carcinoma arising in patients on dialysis","volume":"212","author":"Hori","year":"2007","journal-title":"J Pathol"},{"key":"R95-20260513","doi-asserted-by":"crossref","first-page":"103141","DOI":"10.1016\/j.labinv.2024.103141","article-title":"Atrophic tubules of the kidney have regenerative features and cluster with papillary renal cell carcinoma, indicating a possible cell of origin and implications to early prevention","volume":"105","author":"Wan","year":"2025","journal-title":"Lab Investig J Tech Methods Pathol"},{"key":"R96-20260513","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1097\/PAS.0b013e318299f2d1","article-title":"The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia","volume":"37","author":"Srigley","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"R97-20260513","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/01.pas.0000185382.80844.b1","article-title":"Spectrum of epithelial neoplasms in end-stage renal disease: an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia","volume":"30","author":"Tickoo","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"R98-20260513","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1053\/hupa.2002.125370","article-title":"Atypical epithelial proliferations in acquired renal cystic disease harbor cytogenetic aberrations","volume":"33","author":"Cheuk","year":"2002","journal-title":"Hum Pathol"},{"key":"R99-20260513","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1097\/PAS.0000000000001091","article-title":"Acquired cystic disease-associated renal cell carcinoma (ACD-RCC): a multiinstitutional study of 40 cases with clinical follow-up","volume":"42","author":"Przybycin","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"R100-20260513","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.eururo.2021.11.013","article-title":"Renal neoplasia in polycystic kidney disease: an assessment of tuberous sclerosis complex-associated renal neoplasia and pkd1\/tsc2 contiguous gene deletion syndrome","volume":"81","author":"Gupta","year":"2022","journal-title":"Eur Urol"},{"issue":"1-2","key":"R101-20260513","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000351049","article-title":"Autosomal dominant polycystic kidney disease: prevalence of renal neoplasias in surgical kidney specimens","volume":"123","author":"Jilg","year":"2013","journal-title":"Nephron Clin Pract"},{"key":"R102-20260513","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1159\/000536245","article-title":"Prevalence of renal neoplasia in autosomal dominant polycystic kidney disease: systematic review and meta-analysis","volume":"148","author":"Drake","year":"2024","journal-title":"Nephron"},{"key":"R103-20260513","first-page":"92","article-title":"Epithelial hyperplasia in human polycystic kidney diseases. Its role in pathogenesis and risk of neoplasia","volume":"129","author":"Bernstein","year":"1987","journal-title":"Am J Pathol"},{"key":"R104-20260513","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/ki.1979.191","article-title":"Polypoid and papillary epithelial hyperplasia: a potential cause of ductal obstruction in adult polycystic disease","volume":"16","author":"Evan","year":"1979","journal-title":"Kidney Int"},{"key":"R105-20260513","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1681\/ASN.V571462","article-title":"Proliferative activity of cyst epithelium in human renal cystic diseases","volume":"5","author":"Nadasdy","year":"1995","journal-title":"J Am Soc Nephrol"},{"key":"R106-20260513","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/PAS.0000000000000557","article-title":"Atypical renal cysts: a morphologic, immunohistochemical, and molecular study","volume":"40","author":"Matoso","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R107-20260513","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1097\/00000478-200212000-00002","article-title":"Renal tumors in the Birt-Hogg-Dub\u00e9 syndrome","volume":"26","author":"Pavlovich","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"R108-20260513","first-page":"212A","article-title":"Are cysts the precancerous lesion in HLRCC? The morphologic spectrum of premalignant lesions and associated molecular changes in hereditary renal cell carcinoma: their clinical significance","volume":"26","author":"Ghosh","year":"2013","journal-title":"Mod Pathol"},{"key":"R109-20260513","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.jaad.2025.06.044","article-title":"Increased prevalence of renal cysts in hereditary leiomyomatosis and renal cell cancer: a cross-sectional magnetic resonance imaging-based study","volume":"93","author":"Udupa","year":"2025","journal-title":"J Am Acad Dermatol"},{"key":"R110-20260513","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/his.13183","article-title":"A distinctive, low-grade oncocytic fumarate hydratase-deficient renal cell carcinoma, morphologically reminiscent of succinate dehydrogenase-deficient renal cell carcinoma","volume":"71","author":"Smith","year":"2017","journal-title":"Histopathology"},{"key":"R111-20260513","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/PAP.0000000000000321","article-title":"Low-grade oncocytic fumarate hydratase-deficient renal cell carcinoma: an update on biologic potential, morphologic spectrum, and differential diagnosis with other low-grade oncocytic tumors","volume":"28","author":"Hamza","year":"2021","journal-title":"Adv Anat Pathol"},{"key":"R112-20260513","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1177\/10668969211026241","article-title":"Low-grade fumarate hydratase-deficient renal cell carcinoma in a 30-year-old female","volume":"30","author":"Wyvekens","year":"2022","journal-title":"Int J Surg Pathol"},{"key":"R113-20260513","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s00428-025-04111-8","article-title":"Clinicopathological and molecular features of so-called low-grade oncocytic fumarate hydratase- deficient renal cell carcinoma: a study of 5 cases","volume":"487","author":"Xie","year":"2025","journal-title":"Virch Arch"},{"key":"R114-20260513","doi-asserted-by":"crossref","first-page":"1440119","DOI":"10.3389\/fonc.2024.1440119","article-title":"Case report: a rare low-grade fumarate hydratase-deficient renal cell carcinoma","volume":"14","author":"Sun","year":"2024","journal-title":"Front Oncol"},{"key":"R115-20260513","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1097\/PAS.0000000000000237","article-title":"Renal cell carcinoma in tuberous sclerosis complex","volume":"38","author":"Yang","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"R116-20260513","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1097\/PAS.0000000000000248","article-title":"Tuberous sclerosis- associated renal cell carcinoma: a clinicopathologic study of 57 separate carcinomas in 18 patients","volume":"38","author":"Guo","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"R117-20260513","doi-asserted-by":"crossref","first-page":"400","DOI":"10.5858\/arpa.2011-0485-RA","article-title":"Spectrum of preneoplastic and neoplastic cystic lesions of the kidney","volume":"136","author":"Chen","year":"2012","journal-title":"Arch Pathol Lab Med"},{"key":"R118-20260513","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1038\/sj.ki.5001853","article-title":"Renal manifestations of tuberous sclerosis complex: incidence, prognosis, and predictive factors","volume":"70","author":"Rakowski","year":"2006","journal-title":"Kidney Int"},{"key":"R119-20260513","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1177\/10668969221108747","article-title":"Papillary adenoma-like\u201d renal tumor with TFE3 gene rearrangement, a potential precursor to or early event in the development of TFE3 translocation renal cell carcinoma","volume":"31","author":"Algarrahi","year":"2023","journal-title":"Int J Surg Pathol"},{"key":"R120-20260513","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/mpo.2950210303","article-title":"Precursor lesions of Wilms tumor: clinical and biological implications","volume":"21","author":"Beckwith","year":"1993","journal-title":"Med Pediatr Oncol"},{"key":"R121-20260513","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/(SICI)1096-8628(19981002)79:4<268::AID-AJMG7>3.0.CO;2-I","article-title":"Nephrogenic rests and the pathogenesis of Wilms tumor: developmental and clinical considerations","volume":"79","author":"Beckwith","year":"1998","journal-title":"Am J Med Genet"},{"issue":"1-2","key":"R122-20260513","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/15513819009067094","article-title":"Nephrogenic rests, nephroblastomatosis, and the pathogenesis of Wilms\u2019 tumor","volume":"10","author":"Beckwith","year":"1990","journal-title":"Pediatr Pathol"},{"key":"R123-20260513","doi-asserted-by":"crossref","first-page":"3252","DOI":"10.1245\/s10434-021-11266-6","article-title":"Kidney preservation and Wilms tumor development in children with diffuse hyperplastic perilobar nephroblastomatosis: a report from the Children\u2019s Oncology Group Study AREN0534","volume":"29","author":"Ehrlich","year":"2022","journal-title":"Ann Surg Oncol"},{"key":"R124-20260513","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1097\/PAS.0000000000001864","article-title":"Adult Wilms tumor: genetic evidence of origin of a subset of cases from metanephric adenoma","volume":"46","author":"Argani","year":"2022","journal-title":"Am J Surg Pathol"},{"key":"R125-20260513","doi-asserted-by":"crossref","first-page":"e362","DOI":"10.5858\/arpa.2022-0528-OA","article-title":"BRAF Exon 15 mutations in the evaluation of well-differentiated epithelial nephroblastic neoplasms in children: a report from the Children\u2019s Oncology Group Study AREN03B2","volume":"148","author":"Goldstein","year":"2024","journal-title":"Arch Pathol Lab Med"},{"key":"R126-20260513","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00428-021-03018-4","article-title":"Clear cell clusters in the kidney: a rare finding that should not be misdiagnosed as renal cell carcinoma","volume":"479","author":"Ortiz-Rey","year":"2021","journal-title":"Virchows Arch"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002550","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T07:00:33Z","timestamp":1778655633000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002550"}},"subtitle":["Working Group 3 Preneoplastic and Precursor Lesions of the Kidney"],"short-title":[],"issued":{"date-parts":[[2026,4,29]]},"references-count":122,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000002550","relation":{},"ISSN":["0147-5185","1532-0979"],"issn-type":[{"value":"0147-5185","type":"print"},{"value":"1532-0979","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,29]]},"assertion":[{"value":"2025-10-03","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-15","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}